Trial
NCT04821271
Antidepressant Effects of TS-161 in Treatment-Resistant Depression
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Institute of Mental Health (NIMH)
Collaborators
Taisho Pharmaceutical Co., Ltd.
Condition
Major Depressive Disorder
Intervention
Placebo
Why stopped
due to low recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-10